GRCL - Gracell Biotechnologies EPS beats by $0.16 May, 17 2021 08:37 AM Gracell Biotechnologies Inc. Gracell Biotechnologies (GRCL): Q1 GAAP EPS of -$0.05 beats by $0.16.Cash, cash equivalents and short-term investments of $331.1MPress Release For further details see: Gracell Biotechnologies EPS beats by $0.16